Literature DB >> 3127093

Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.

E Braakman1, P Treep-van Leeuwen, R J ten Berge, P T Schellekens, C J Lucas.   

Abstract

We have examined the role of interleukin 2, interferon-gamma and interferon-alpha in the generation of natural cytotoxic (NC) activity and cytotoxic T-lymphocyte (CTL) activity in peripheral blood lymphocyte cultures stimulated with influenza virus, using the immunosuppressive effects of prednisolone. In addition to an inhibitory effect on the generation of CTL activity, prednisolone also inhibited the generation of NC activity in a similar dose-and time-dependent manner. Prednisolone suppressed the production of interferon-gamma when it was added on the first day of culture of PBL with influenza virus. Levels of interferon-alpha were not affected. The effects of prednisolone on the generation of NC activity and CTL activity in kinetic terms were not paralleled by the effects on interferon-alpha and interferon-gamma production. The diminished generation of NC activity could be reversed by the addition of interleukin 2 (IL-2), but interferon-gamma had little if any restorative effects. Interferon-alpha had no effect. These findings support the hypothesis that IL-2 is the major inducer of NC activity in CTL generation cultures. The inhibitory effect on CTL generation could only be reversed by IL-2 and not by interferon-alpha- and interferon-gamma. Thus, in the absence of IL-2, interferon-alpha and interferon-gamma cannot support the generation of CTL activity or the concomitantly induced NC activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127093      PMCID: PMC1541452     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

Authors:  J L Virelizier; A C Allison; E de Maeyer
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

3.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

4.  Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

Authors:  J M Zarling; J Sosman; L Eskra; E C Borden; J S Horoszewicz; W A Carter
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

5.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  The effect of T cell growth factor on the generation of cytolytic T cells.

Authors:  P E Baker; S Gillis; M M Ferm; K A Smith
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.

Authors:  W E Biddison; F E Ward; G M Shearer; S Shaw
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

9.  Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.

Authors:  E Bloemena; M H Van Oers; S Weinreich; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

10.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.